Caley Castelein - 12 Jun 2024 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Jun 2024, 16:06:38 UTC
Prior SEC filing
07 Jun 2024
Next SEC filing
04 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Rodin, as Attorney-in-Fact

Key filing fact

Caley Castelein filed Form 4 for Aadi Bioscience, Inc. (WHWK) on 14 Jun 2024.

Key facts

  • This page summarizes Caley Castelein's Form 4 filing for Aadi Bioscience, Inc. (WHWK).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 14 Jun 2024, 16:06.

Change

  • Previous filing in this sequence was filed on 07 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AADI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+45,832
Change %
Price
$0.000000
Shares after
45,832
Date
12 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
45,832
Exercise price
$1.70
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .